Drug class

The Amylin/GLP-1 class

Amylin/GLP-1 medications, with sourced prices, shortage reports and study results.

Last updated

Last checked · Nov 16, 2026 UTC
0approved
2in development

No FDA-approved GLP-1 in this category yet

The medications below are in late-stage development for it.

Investigational (pipeline)

Alphabetical by active ingredient. These entries are not FDA-approved for this category; open a record for the studied uses and evidence.

Amycretin

Amycretin (investigational)

Studied for

  • Weight loss
  • Type 2 diabetes

Subcutaneous injection and oral tablet (both in development) · Once weekly (injectable); once daily (oral)

Investigational. No FDA-approved purchase option.

Study evidence & development
GLPcompare is an informational data platform, not a medical provider or pharmacy. Nothing here is medical advice, a diagnosis, or a recommendation to start, stop, or change any treatment. Data is aggregated from public sources and can be incomplete or out of date. Always confirm with a licensed clinician and the current FDA label.